MA42309A - Nouveau composé de tiacumicine pour régime posologique - Google Patents

Nouveau composé de tiacumicine pour régime posologique

Info

Publication number
MA42309A
MA42309A MA042309A MA42309A MA42309A MA 42309 A MA42309 A MA 42309A MA 042309 A MA042309 A MA 042309A MA 42309 A MA42309 A MA 42309A MA 42309 A MA42309 A MA 42309A
Authority
MA
Morocco
Prior art keywords
new
dosage regime
tiacumicin compound
tiacumicin
compound
Prior art date
Application number
MA042309A
Other languages
English (en)
Inventor
Leticia Delgado-Herrera
Andreas Johannis Karas
Christopher Mark Longshaw
Bernhardt George Zeiher
Original Assignee
Astellas Pharma Europe Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Europe Ltd filed Critical Astellas Pharma Europe Ltd
Publication of MA42309A publication Critical patent/MA42309A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
MA042309A 2015-07-03 2016-07-04 Nouveau composé de tiacumicine pour régime posologique MA42309A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15075021 2015-07-03

Publications (1)

Publication Number Publication Date
MA42309A true MA42309A (fr) 2021-03-24

Family

ID=53672983

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042309A MA42309A (fr) 2015-07-03 2016-07-04 Nouveau composé de tiacumicine pour régime posologique

Country Status (10)

Country Link
US (1) US10548912B2 (fr)
EP (1) EP3316892B1 (fr)
JP (3) JP2018519344A (fr)
AU (1) AU2016289307A1 (fr)
CA (1) CA2990961A1 (fr)
EA (1) EA034885B1 (fr)
IL (1) IL256576B (fr)
MA (1) MA42309A (fr)
WO (1) WO2017005358A1 (fr)
ZA (1) ZA201800217B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11493262B2 (en) * 2013-01-18 2022-11-08 Triteq Lock And Security, L.L.C. Cooler lock

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5583115A (en) 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
US5767096A (en) 1996-07-12 1998-06-16 Abbott Laboratories Bromotiacumicin compounds
US20070105791A1 (en) * 2002-07-29 2007-05-10 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
CA2494742C (fr) 2002-07-29 2015-05-12 Optimer Pharmaceuticals, Inc. Fabrication de tiacumicine
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
EP1848273A4 (fr) 2005-01-31 2010-02-24 Optimer Pharmaceuticals Inc Macrocycles a 18 chainons et leurs analogues
US20120276060A1 (en) * 2011-04-29 2012-11-01 Techlab, Inc. Fecal lactoferrin as a biomarker for determining disease severity and for treating infection in patients with clostridium difficile disease
CA2948400A1 (fr) * 2014-05-09 2015-11-12 Astellas Pharma Europe Ltd Compose de tiacumicine et regime de traitement associe

Also Published As

Publication number Publication date
ZA201800217B (en) 2019-06-26
WO2017005358A1 (fr) 2017-01-12
EA201890101A1 (ru) 2018-07-31
EP3316892A1 (fr) 2018-05-09
JP2021193088A (ja) 2021-12-23
AU2016289307A1 (en) 2018-01-18
US20180193370A1 (en) 2018-07-12
IL256576A (en) 2018-02-28
CA2990961A1 (fr) 2017-01-12
JP2023182594A (ja) 2023-12-26
EP3316892C0 (fr) 2023-07-19
EA034885B1 (ru) 2020-04-02
US10548912B2 (en) 2020-02-04
JP2018519344A (ja) 2018-07-19
EP3316892B1 (fr) 2023-07-19
IL256576B (en) 2021-01-31

Similar Documents

Publication Publication Date Title
IL258213A (en) Pharmaceutical compounds
GB201511790D0 (en) Pharmaceutical compound
GB201419579D0 (en) Pharmaceutical compound
GB201414730D0 (en) Pharmaceutical compound
GB201506658D0 (en) Pharmaceutical compounds
IL258246A (en) Pharmaceutical compounds
PL2990031T3 (pl) Pozajelitowa postać norepinefryny
GB201504675D0 (en) Pharmaceutical compounds
GB201506660D0 (en) Pharmaceutical compounds
GB201519352D0 (en) Pharmaceutical compounds
MA42840A (fr) Composé pharmaceutique
GB201506933D0 (en) Pharmaceutical compounds
HK1249901B (zh) 用於抑制ror-gamma-t的化合物
GB201502567D0 (en) Pharmaceutical compounds
SG11201708818VA (en) Pharmaceutical compound
MA42309A (fr) Nouveau composé de tiacumicine pour régime posologique
SG11201708817XA (en) Pharmaceutical compound
GB201517451D0 (en) Pharmaceutical compounds
FR3043314B1 (fr) Semelle chauffante pour chaussure
GB201507883D0 (en) Pharmaceutical compound
GB201502156D0 (en) Pharmaceutical compound
FR3031123B1 (fr) Montant pour cloison
GB201419570D0 (en) Pharmaceutical compound
TH1501007274A (th) สารประกอบเบนโซไทโอฟิน (Benzothiophene Compound)
GB201411215D0 (en) Pharmaceutical compound